NEW YORK ( TheStreet) -- In the wake of reporting quarterly results new data received by ValuEngine can result in upgrades or downgrades to the stocks I profiled pre-earnings. A stock can also have a ratings change if the directional volatility outruns its price target to the upside and triggers a downgrade, or falls far enough below its price target to merit an upgrade.Amazon.com ( AMZN) ($254.81 vs. $274.70 Friday) has been upgraded to hold from strong sell following its $19.89 price plunge Friday. The stock is still overvalued by 6.0% and is projected to slide another 4.3%, but since this is within a plus/minus 5.0% projection range the upgrade to hold occurred. My semiannual and annual value levels are $241.23 and $226.80 with a weekly pivot at $258.38 and quarterly risky level at $278.28. Qualcomm ( QCOM) ($61.52) has been upgraded to buy from hold as the stock fell below its 200-day simple moving average at $65.66 last Thursday. The stock is 12.3% undervalued and is projected to gain 6.1% over the next 12 months. With this projection above 5.0% the stock merited the upgrade. My annual value level is $53.29 with a weekly pivot at $63.32 and quarterly and semiannual risky levels at $65.63 and $67.43. Last week's high was a test of the zone of risky levels. Du Pont ( DD) ($52.90) has been downgraded to sell from hold after the Dow component outran its valuations and forecast projections. The stock has become 7.2% overvalued and is projected to decline 6.0% over the next 12 months justifying the downgrade. My quarterly value level is $42.11 with a weekly pivot at $52.13 and semiannual risky level at $60.06.
Today I profile seven stocks that report quarterly results with the theme of getting a fresh read on big Pharma, healthcare providers and spending via credit cards.
Reading the TableOV/UN Valued: Stocks with a red number are undervalued by this percentage. Those with a black number are overvalued by that percentage according to ValuEngine. VE Rating: A "1-engine" rating is a strong sell, a "2-engine" rating is a sell, a "3-engine" rating is a hold, a "4-engine" rating is a buy and a "5-engine" rating is a strong buy. Last 12-Month Return (%): Stocks with a red number declined by that percentage over the last 12 months. Stocks with a black number increased by that percentage. Forecast 1-Year Return: Stocks with a red number are projected to decline by that percentage over the next 12 months. Stocks with a black number in the table are projected to move higher by that percentage over the next 12 months. Value Level: Price at which to enter a GTC limit order to buy on weakness. The letters mean; W-weekly, M-monthly, Q-quarterly, S-semiannual and A-annual. Pivot: A level between a value level and risky level that should be a magnet during the time frame noted. Risky Level: Price at which to enter a GTC limit order to sell on strength.
Reporting pre-market Tuesday, Pfizer ( PFE) ($30.09) set a multi-year high at $31.15 on April 23. The weekly chart profile is positive but overbought with the five-week modified moving average at $29.28. My quarterly value level is $27.07 with a weekly risky level is $31.38.
Reporting after the close on Wednesday is Visa ( V) ($167.23) set a multi-year high at $170.99 on April 1. The weekly chart profile shifts to negative with a weekly close below the five-week MMA at $163.59. My semiannual value level is $148.31 with a weekly pivot at $170.47 and quarterly risky level is $179.42.
Reporting pre-market on Friday, WellCare Health Plans ( WCG) ($30.09) set a multi-year high at $74.41 on April 5, 2012. The weekly chart profile shifts to negative on a close this week below the five-week MMA at $57.72. My semiannual value level is $36.67 with a weekly pivot at $59.70 and quarterly risky level at $66.48. At the time of publication the author held no positions in any of the stocks mentioned. Follow @Suttmeier This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.